Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Conditions: Major Depressive Disorder; Depression; Treatment-Resistant Depression; Mood Disorders Interventions: Drug: Single Psychedelic Dose Psilocybin; Drug: Two Psychedelic Doses Psilocybin Sponsors: University Health Network, Toronto; Centre for Addiction and Mental Health Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials